There are 2789 resources available
1212P - Afatinib for the treatment of NSCLC with uncommon EGFR mutations: An updated database of 1023 cases
Presenter: James Yang Yang
Session: ePoster Display
1213P - Clinical utility of liquid biopsy for the early diagnosis of EGFR mutant advanced lung cancer in a real-life setting (CLEAR)
Presenter: Rami Nassabein
Session: ePoster Display
1214P - High dose osimertinib in patients with advanced stage EGFR exon 20 mutation-positive NSCLC: Results from a phase II multicenter study, POSITION20
Presenter: Fenneke Zwierenga
Session: ePoster Display
1215P - EGFR-mutated squamous cell lung cancer and its association with outcomes
Presenter: Yang Xia
Session: ePoster Display
1217P - EGFR TKIs in patients (pts) with NSCLC with uncommon EGFR mutations: A real-world cohort study (UpSwinG)
Presenter: Satoru Miura
Session: ePoster Display
1265P - Combined detection of tumor markers and ctDNA in cerebrospinal fluid: A good strategy in diagnosis of leptomeningeal metastases
Presenter: Yong Wang
Session: ePoster Display
1266P - Genetic profiling of cell-free DNA from pleural effusion in advanced lung cancer as a surrogate for tumor tissue and revealed additional clinical actionable targets
Presenter: Hai-Yan Tu
Session: ePoster Display
1147P - AI-based detection of molecular biomarkers directly from H&E scanned slide
Presenter: Nir Peled
Session: ePoster Display